1. Home
  2. EM vs SGMT Comparison

EM vs SGMT Comparison

Compare EM & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EM
  • SGMT
  • Stock Information
  • Founded
  • EM 2017
  • SGMT 2006
  • Country
  • EM China
  • SGMT United States
  • Employees
  • EM N/A
  • SGMT N/A
  • Industry
  • EM Other Consumer Services
  • SGMT
  • Sector
  • EM Consumer Discretionary
  • SGMT
  • Exchange
  • EM Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • EM 286.5M
  • SGMT 269.2M
  • IPO Year
  • EM 2021
  • SGMT 2023
  • Fundamental
  • Price
  • EM $1.15
  • SGMT $10.24
  • Analyst Decision
  • EM Hold
  • SGMT Strong Buy
  • Analyst Count
  • EM 1
  • SGMT 6
  • Target Price
  • EM $1.25
  • SGMT $26.83
  • AVG Volume (30 Days)
  • EM 124.6K
  • SGMT 863.2K
  • Earning Date
  • EM 08-21-2025
  • SGMT 08-13-2025
  • Dividend Yield
  • EM N/A
  • SGMT N/A
  • EPS Growth
  • EM N/A
  • SGMT N/A
  • EPS
  • EM N/A
  • SGMT N/A
  • Revenue
  • EM $259,541,587.00
  • SGMT N/A
  • Revenue This Year
  • EM $3.30
  • SGMT N/A
  • Revenue Next Year
  • EM $5.26
  • SGMT N/A
  • P/E Ratio
  • EM N/A
  • SGMT N/A
  • Revenue Growth
  • EM N/A
  • SGMT N/A
  • 52 Week Low
  • EM $0.50
  • SGMT $1.73
  • 52 Week High
  • EM $1.17
  • SGMT $11.41
  • Technical
  • Relative Strength Index (RSI)
  • EM 64.31
  • SGMT 66.92
  • Support Level
  • EM $1.10
  • SGMT $8.79
  • Resistance Level
  • EM $1.15
  • SGMT $9.83
  • Average True Range (ATR)
  • EM 0.02
  • SGMT 0.80
  • MACD
  • EM -0.00
  • SGMT -0.07
  • Stochastic Oscillator
  • EM 83.33
  • SGMT 59.93

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: